What are the chances of the eFFECTOR Therapeutics Inc (EFTR) Stock tortoise growing into a hare?
Stifel lowered the price target for the eFFECTOR Therapeutics Inc (NASDAQ:EFTR) stock from “a Buy” to “a Hold”. The rating was released on January 25, 2022, according to finviz. The research report from Credit Suisse has initiated the stock to Outperform, with a price target set at $20. The stock was initiated by Mizuho, who […]
It’s Better to Hope for Prosperity than Become Adversary: eFFECTOR Therapeutics Inc (EFTR) Stock
Stifel lowered the price target for the eFFECTOR Therapeutics Inc (NASDAQ:EFTR) stock from “a Buy” to “a Hold”. The rating was released on January 25, 2022, according to finviz. The research report from Credit Suisse has initiated the stock to Outperform, with a price target set at $20. The stock was initiated by Mizuho, who […]